Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland R Griffiths

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Journal of Psychoactive Drugs|May 8, 2024
Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal StudySandeep M Nayak, Sydney H White, Samantha N Hilbert, et al.
Scientific Reports|October 3, 2020
The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human BrainManoj K Doss, Darrick G May, Matthew W Johnson, et al.
JAMA Psychiatry|November 4, 2020
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical TrialAlan K Davis, Frederick S Barrett, Darrick G May, et al.
Plos One|March 14, 2024
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderAdam W Levin, Rafaelle Lancelotta, Nathan D Sepeda, et al.
The International Journal of Neuropsychopharmacology|May 14, 2021
Psychedelics and Consciousness: Distinctions, Demarcations, and OpportunitiesDavid B Yaden, Matthew W Johnson, Roland R Griffiths, et al.
Journal of Psychopharmacology (Oxford, England)|October 13, 2017
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviorsRoland R Griffiths, Matthew W Johnson, William A Richards, et al.
Drug and Alcohol Dependence|April 4, 2006
Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel reportCharles Grudzinskas, Robert L Balster, Charles W Gorodetzky, et al.
Translational Psychiatry|November 9, 2021
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorderManoj K Doss, Michal Považan, Monica D Rosenberg, et al.
The International Journal of Neuropsychopharmacology|June 7, 2015
Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in HumansAna Elda Maqueda, Marta Valle, Peter H Addy, et al.
Journal of Psychoactive Drugs|September 25, 2023
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global HealthJulian Urrutia, Brian T Anderson, Sean J Belouin, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Journal of Psychoactive Drugs|May 8, 2024
Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal StudySandeep M Nayak, Sydney H White, Samantha N Hilbert, et al.
Scientific Reports|October 3, 2020
The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human BrainManoj K Doss, Darrick G May, Matthew W Johnson, et al.
JAMA Psychiatry|November 4, 2020
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical TrialAlan K Davis, Frederick S Barrett, Darrick G May, et al.
Plos One|March 14, 2024
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderAdam W Levin, Rafaelle Lancelotta, Nathan D Sepeda, et al.
The International Journal of Neuropsychopharmacology|May 14, 2021
Psychedelics and Consciousness: Distinctions, Demarcations, and OpportunitiesDavid B Yaden, Matthew W Johnson, Roland R Griffiths, et al.
Journal of Psychopharmacology (Oxford, England)|October 13, 2017
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviorsRoland R Griffiths, Matthew W Johnson, William A Richards, et al.
Drug and Alcohol Dependence|April 4, 2006
Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel reportCharles Grudzinskas, Robert L Balster, Charles W Gorodetzky, et al.
Translational Psychiatry|November 9, 2021
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorderManoj K Doss, Michal Považan, Monica D Rosenberg, et al.
The International Journal of Neuropsychopharmacology|June 7, 2015
Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in HumansAna Elda Maqueda, Marta Valle, Peter H Addy, et al.
Journal of Psychoactive Drugs|September 25, 2023
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global HealthJulian Urrutia, Brian T Anderson, Sean J Belouin, et al.
Pageof 14